S&P 500   3,283.04 (+0.37%)
DOW   26,497.17 (-0.09%)
QQQ   275.23 (+1.32%)
AAPL   114.11 (+2.62%)
MSFT   204.96 (+1.12%)
FB   278.08 (+3.89%)
GOOGL   1,547.11 (+2.40%)
AMZN   3,199.39 (+1.16%)
TSLA   410.77 (+1.17%)
NVDA   518.74 (+2.70%)
BABA   313.41 (+1.78%)
CGC   18.41 (+0.38%)
GE   7.63 (+2.83%)
MU   50.27 (+0.54%)
AMD   78.23 (+2.40%)
T   26.70 (+0.75%)
F   8.18 (+6.23%)
ACB   3.95 (+3.13%)
GILD   57.82 (-1.53%)
NFLX   482.52 (-0.77%)
NIO   29.89 (+8.65%)
BA   148.78 (+0.43%)
DIS   119.79 (+1.11%)
S&P 500   3,283.04 (+0.37%)
DOW   26,497.17 (-0.09%)
QQQ   275.23 (+1.32%)
AAPL   114.11 (+2.62%)
MSFT   204.96 (+1.12%)
FB   278.08 (+3.89%)
GOOGL   1,547.11 (+2.40%)
AMZN   3,199.39 (+1.16%)
TSLA   410.77 (+1.17%)
NVDA   518.74 (+2.70%)
BABA   313.41 (+1.78%)
CGC   18.41 (+0.38%)
GE   7.63 (+2.83%)
MU   50.27 (+0.54%)
AMD   78.23 (+2.40%)
T   26.70 (+0.75%)
F   8.18 (+6.23%)
ACB   3.95 (+3.13%)
GILD   57.82 (-1.53%)
NFLX   482.52 (-0.77%)
NIO   29.89 (+8.65%)
BA   148.78 (+0.43%)
DIS   119.79 (+1.11%)
S&P 500   3,283.04 (+0.37%)
DOW   26,497.17 (-0.09%)
QQQ   275.23 (+1.32%)
AAPL   114.11 (+2.62%)
MSFT   204.96 (+1.12%)
FB   278.08 (+3.89%)
GOOGL   1,547.11 (+2.40%)
AMZN   3,199.39 (+1.16%)
TSLA   410.77 (+1.17%)
NVDA   518.74 (+2.70%)
BABA   313.41 (+1.78%)
CGC   18.41 (+0.38%)
GE   7.63 (+2.83%)
MU   50.27 (+0.54%)
AMD   78.23 (+2.40%)
T   26.70 (+0.75%)
F   8.18 (+6.23%)
ACB   3.95 (+3.13%)
GILD   57.82 (-1.53%)
NFLX   482.52 (-0.77%)
NIO   29.89 (+8.65%)
BA   148.78 (+0.43%)
DIS   119.79 (+1.11%)
S&P 500   3,283.04 (+0.37%)
DOW   26,497.17 (-0.09%)
QQQ   275.23 (+1.32%)
AAPL   114.11 (+2.62%)
MSFT   204.96 (+1.12%)
FB   278.08 (+3.89%)
GOOGL   1,547.11 (+2.40%)
AMZN   3,199.39 (+1.16%)
TSLA   410.77 (+1.17%)
NVDA   518.74 (+2.70%)
BABA   313.41 (+1.78%)
CGC   18.41 (+0.38%)
GE   7.63 (+2.83%)
MU   50.27 (+0.54%)
AMD   78.23 (+2.40%)
T   26.70 (+0.75%)
F   8.18 (+6.23%)
ACB   3.95 (+3.13%)
GILD   57.82 (-1.53%)
NFLX   482.52 (-0.77%)
NIO   29.89 (+8.65%)
BA   148.78 (+0.43%)
DIS   119.79 (+1.11%)
Log in
NASDAQ:REGN

Regeneron Pharmaceuticals Price Target, Predictions & Analyst Ratings

$565.00
-2.04 (-0.36 %)
(As of 10/29/2020 10:03 AM ET)
Add
Compare
Today's Range
$563.30
Now: $565.00
$583.00
50-Day Range
$544.75
MA: $575.92
$607.98
52-Week Range
$303.49
Now: $565.00
$664.64
Volume5,235 shs
Average Volume1.14 million shs
Market Capitalization$60.11 billion
P/E Ratio21.87
Dividend YieldN/A
Beta0.51

Analyst Ratings

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
24 Wall Street analysts have issued ratings and price targets for Regeneron Pharmaceuticals in the last 12 months. Their average twelve-month price target is $622.13, predicting that the stock has a possible upside of 10.11%. The high price target for REGN is $800.00 and the low price target for REGN is $429.00. There are currently 9 hold ratings, 14 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
REGN Consensus Rating: BuyBuyBuyHold
REGN Consensus Rating Score: 2.672.622.592.48
REGN Analyst Ratings: 0 Sell Rating(s)
9 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
12 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
14 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
REGN Consensus Price Target: $622.13$600.08$576.22$480.77
REGN Price Target Upside: 10.11% upside9.75% upside9.23% upside8.64% upside

Regeneron Pharmaceuticals (NASDAQ:REGN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/13/2020Morgan StanleyLower Price TargetEqual Weight$611.00 ➝ $609.00Low
10/6/2020SVB LeerinkBoost Price TargetOutperform$629.00 ➝ $650.00High
10/5/2020Cantor FitzgeraldUpgradeNeutral ➝ Overweight$690.00High
10/1/2020JPMorgan Chase & Co.Reiterated RatingHoldHigh
8/20/2020BenchmarkDowngradeBuy ➝ HoldHigh
8/7/2020Credit Suisse GroupBoost Price TargetOutperform$716.00 ➝ $725.00Low
8/6/2020BarclaysBoost Price Target$615.00 ➝ $675.00Low
8/6/2020OppenheimerBoost Price TargetOutperform$675.00 ➝ $725.00Low
8/6/2020CitigroupBoost Price TargetNeutral$585.00 ➝ $635.00Low
8/6/2020BMO Capital MarketsBoost Price TargetOutperform$525.00 ➝ $626.00Low
8/5/2020The Goldman Sachs GroupBoost Price Target$700.00 ➝ $800.00Low
8/5/2020Piper SandlerBoost Price TargetOverweight$630.00 ➝ $675.00High
7/8/2020SunTrust BanksUpgradeHold ➝ Buy$400.00 ➝ $750.00Low
7/8/2020Canaccord GenuityBoost Price TargetBuy$600.00 ➝ $700.00Low
6/12/2020Jefferies Financial GroupBoost Price TargetBuy$657.00 ➝ $691.00High
6/2/2020CowenReiterated RatingHold$584.00Low
5/27/2020CfraLower Price TargetHold$557.00 ➝ $549.00Low
5/26/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$559.00 ➝ $734.00High
5/6/2020Robert W. BairdBoost Price TargetNeutral ➝ Neutral$487.00 ➝ $510.00High
5/6/2020Royal Bank of CanadaLower Price Target$533.00 ➝ $524.00Medium
3/31/2020Wolfe ResearchInitiated CoverageMarket Perform$455.00High
3/12/2020ArgusBoost Price TargetBuy$430.00 ➝ $540.00High
2/26/2020Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$500.00Medium
2/24/2020Evercore ISIUpgradeIn-Line ➝ Outperform$500.00High
12/23/2019Raymond JamesInitiated CoverageMarket PerformN/A
10/16/2019Bank of AmericaInitiated CoverageNeutral$325.00Low
10/8/2019Piper Jaffray CompaniesSet Price TargetBuy$435.00Low
9/23/2019GuggenheimUpgradeNeutral ➝ Buy$355.00 ➝ $403.00Low
5/8/2019UBS GroupLower Price TargetBuy$480.00 ➝ $440.00Medium
3/13/2018BTIG ResearchReiterated RatingHoldMedium
3/13/2018Deutsche Bank AktiengesellschaftSet Price TargetHold$367.00Medium
(Data available from 10/29/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.